| Nabih I Abdou, MD, PH D | |
|
4330 Wornall Rd, Med Plaza Ii, 4th Floor, Kansas City, MO 64111-3217 | |
| (816) 531-0930 | |
| (816) 753-2671 |
| Full Name | Nabih I Abdou |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 4330 Wornall Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013979210 | NPI | - | NPPES |
| 05110011 | Other | MO | BCBS |
| 66329 | Other | KS | BCBS |
| Mailing Address | Practice Location Address |
|---|---|
| Nabih I Abdou, MD, PH D 4330 Wornall Rd, Med Plaza Ii, 4th Floor, Kansas City, MO 64111-3217 Ph: (816) 531-0930 | Nabih I Abdou, MD, PH D 4330 Wornall Rd, Med Plaza Ii, 4th Floor, Kansas City, MO 64111-3217 Ph: (816) 531-0930 |
News Archive
The Johns Hopkins Brain Sciences Institute has funded a total of $5 million to 12 different research groups at Hopkins to launch the new Synapses, Circuits and Cognitive Disorders Program. The new BSi program aims to understand the fundamentals of brain function by focusing on the synapse — the point of contact between two nerve cells — to better understand cognitive disorders.
Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) that concluded with oral proceedings on May 12, 2009 in Munich, Germany.
Some community parks are square, a reflection of the city block where they're located - but irregularly shaped parks reduce the mortality risk of residents who live near them, concluded a study by Huaquing Wang, a Ph.D. Urban and Regional Sciences student and Lou Tassinary, professor of visualization.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 1 days ago
Maria Akram Sheikh, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |